Metastatic Cancer Stem Cells: An Opportunity for Improving Cancer Treatment?

Cancer Center, Stanford University School of Medicine, Palo Alto, CA 94305, USA.
Cell stem cell (Impact Factor: 22.15). 06/2010; 6(6):502-3. DOI: 10.1016/j.stem.2010.05.001
Source: PubMed

ABSTRACT Many human cancers are driven by cancer stem cells (CSCs) whose connection to metastatic spread remains incompletely understood. In this issue of Cell Stem Cell, Pang et al. (2010) isolate a subpopulation of human colorectal CSCs that uniquely possesses metastatic potential.

  • [Show abstract] [Hide abstract]
    ABSTRACT: A growing body of experimental and clinical evidence strongly suggest that the resistance of cancer initiating cells (CICs) to conventional therapies represents a major obstacle to the successful treatment of a malignant disease. To overcome this limitation a novel combinatorial tumor antigen (TA)-specific monoclonal antibody (mAb) strategy has been developed. In this strategy TA-specific mAbs are combined with chemotherapeutic agents and/or small molecules which inhibit aberrantly activated signaling pathways in cancer cells and especially in CICs. The in vitro results we have obtained indicates that this strategy is very effective in eradicating both differentiated cancer cells and CICs in several types of malignant disease. If the in vitro results have in vivo relevance the strategy we have designed may have an impact on the treatment of malignant diseases.
    Seminars in Oncology 08/2014; 41(5). DOI:10.1053/j.seminoncol.2014.08.007 · 3.94 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Abstract Significance: Functional stem cell decline has been postulated to result in loss of maintenance of tissue homeostasis leading to organismal decline and diseases of aging. Recent Advances: Recent findings implicate redox metabolism in the control of stem cell pool and stem cell aging. Although reactive oxygen species (ROS) are better known for their damaging properties to DNA, proteins and lipids, recent findings suggest that ROS may also be an integral physiological mediator of cellular signaling in primary cells. Critical Issues: Here we review recent published work on major signaling pathways and transcription factors that are regulated by ROS and mediate ROS regulation of stem cell fate. We will specifically focus on how alterations in this regulation may be implicated in disease and particularly in diseases of stem cell aging. In general, based on the work described here we propose a model in which ROS function as stem cell rheostat. Future Directions: Future work in elucidating how ROS control stem cell cycling, apoptotic machinery, and lineage determination should shed light on mechanisms whereby ROS may control stem cell aging. Antioxid. Redox Signal. 00, 000-000.
    Antioxidants & Redox Signaling 01/2014; DOI:10.1089/ars.2013.5300 · 7.67 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Drosophila can exhibit classic hallmarks of cancer, such as evasion of apoptosis, sustained proliferation, metastasis, prolonged survival, genome instability and metabolic reprogramming, when cancer-related genes are perturbed. In the last two decades studies in flies have identified several tumor suppressor and oncogenes. However, the greatest strength of the fly lies in its ability to model cancer hallmarks in a variety of tissue types, which enables the study of context-dependent tumorigenesis. We review the organs and tissues that have been used to model tumor formation, and propose new strategies to maximize the potential of Drosophila in cancer research. J. Cell. Physiol. © 2013 Wiley Periodicals, Inc.
    Journal of Cellular Physiology 07/2013; 229(1). DOI:10.1002/jcp.24427 · 3.87 Impact Factor